食管放疗中心脏剂量-生存空间关联图谱
本研究基于452例接受根治性放疗的中下段食管癌患者,将计划CT和剂量分布形变配准至共同参考解剖进行体素分析,发现一个与12个月生存显著相关的局域心脏区域,该区域部分重叠肺来源心脏回避区(CAA)及左心房;CAA最大剂量43.5 Gy可显著分层生存,且为 multivariable 分析中的独立生存预测因子。
要点
- 食管放疗中,心脏局部区域高剂量与12个月生存差显著相关。
- 该区域部分重叠肺放疗定义的CAA及左心房。
- CAA最大剂量43.5 Gy可显著分层生存,低剂量组中位生存更优。
核心结论
- 基于图像数据挖掘识别出食管放疗后与生存相关的放射敏感心脏区域,该区域重叠肺癌放疗已建立的CAA。
- 空间定义的心脏剂量指标具有相关性,提示靶向心脏回避在食管放疗计划中可能有作用。
研究设计与样本
- 回顾性队列研究,纳入2009至2024年某大型机构数据库中接受根治性放疗的中段或下段食管癌患者452例。
- 将计划CT图像和剂量分布形变配准至共同参考解剖,进行体素分析。
- 通过比较12个月时存活与死亡患者的剂量评估体素水平剂量-生存关联,并用置换检验校正多重比较。
- 量化CAA剂量,采用Kaplan-Meier分析和包含临床协变量的多变量Cox回归评估生存。
主要发现
- 体素分析识别出一个空间局限的心脏区域,该区域较高放疗剂量与较差的12个月生存显著相关,超过置换检验显著性的第99百分位数。
- 该区域部分重叠肺来源的CAA和左心房。
- CAA最大剂量阈值43.5 Gy产生显著的生存分层,接受较低剂量患者的中位生存改善。
- 多变量分析中CAA最大剂量仍为生存的独立预测因子。
关键数值与推荐
- CAA最大剂量阈值43.5 Gy可显著分层生存。
- 体素分析显著性超过置换检验的第99百分位数。
- 共纳入452例患者。
临床怎么用
- 食管放疗计划中可考虑评估CAA最大剂量,将其作为潜在的可优化心脏剂量指标。
- 对CAA区域实施靶向心脏回避可能有助于改善生存,但需进一步验证。
局限性
- 回顾性研究设计可能引入选择偏倚。
- 体素分析基于形变配准至共同参考解剖,配准精度可能影响结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate spatial associations between cardiac radiation dose and survival following radiotherapy for oesophageal cancer, and to assess whether a previously defined Cardiac Avoidance Area (CAA) from lung radiotherapy is relevant in this patient population. MATERIALS AND METHODS: Patients treated with curative-intent radiotherapy for middle or lower oesophageal cancer between 2009 and 2024 were identified from a large institutional database. Planning CT images and dose distributions were deformably registered to a common reference anatomy for voxel-based analysis. Dose-survival associations were assessed voxel-wise by comparing dose between patients alive and deceased at 12 months, with permutation testing for multiple comparisons. Dose to the CAA was quantified, and survival was evaluated using Kaplan-Meier analysis and multivariable Cox regression including clinical covariates. RESULTS: A total of 452 patients were included. Voxel-based analysis identified a spatially localised heart region where higher radiation dose was significantly associated with poorer 12-month survival, exceeding the 99th percentile of permutation-derived significance. This region partially overlapped with the lung-derived CAA and the left atrium. A maximum CAA dose threshold of 43.5 Gy produced significant survival stratification, with improved median survival in patients receiving lower doses. Maximum CAA dose remained an independent predictor of survival on multivariable analysis. CONCLUSION: Image-based data mining identified a radiosensitive cardiac region associated with survival after oesophageal radiotherapy, overlapping the established CAA from lung cancer. These findings support the relevance of spatially defined cardiac dose metrics and suggest a potential role for targeted cardiac avoidance in oesophageal radiotherapy planning.
引用
- Marchant T, Radhakrishna G, Sheikh H, et al. Spatial mapping of cardiac dose-survival associations in oesophageal radiotherapy. Radiother Oncol. 2026. PMID: 42697274. doi:10.1016/j.radonc.2026.111770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。